WAINUA
Generic Name/API: eplontersen
Manufacturer: AstraZeneca Pharmaceuticals LP
Dosage Forms & Strength & Pack Size:
Injection: 45 mg/0.8 mL in a single-dose autoinjector.
Storage:
Store refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton protected from light.
If needed, WAINUA can be kept at room temperature (up to 30°C [86°F]) in the original
carton for up to 6 weeks. If not used within the 6 weeks stored at room temperature,
discard WAINUA.
Do not freeze. Do not expose to heat.
INDICATION
WAINUA injection, for subcutaneous use, 45 mg is a prescription medicine used to treat adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis.
IMPORTANT RISK INFORMATION
WAINUA may cause side effects, including:
Low vitamin A level, which is a serious, but common side effect of treatment with WAINUA. Your doctor should tell you to take vitamin A supplements. Do not take more than the amount of vitamin A your doctor has recommended. Call your doctor if you develop eye problems such as difficulty seeing at night or in low-lit areas (night blindness), or dry eyes. If you develop eye problems, your doctor should refer you to an eye doctor
The most common side effects include decreased vitamin A and vomiting.
Before you take WAINUA, tell your healthcare provider:
if you are pregnant or breastfeeding, or plan to become pregnant or breastfeed. It is not known if WAINUA can harm your baby. Changes in vitamin A levels and vitamin A supplementation related to use of WAINUA may harm your unborn baby. It is not known if WAINUA passes into breast milk
about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take vitamin A or beta-carotene supplements
*The contents of this site are for reference only. We do not offer drug procurement service. All information must not be used for any commercial purpose.
